Iraqi Judoka Fails First Doping Test of Paris 2024 Olympics

Iraqi Judoka Fails First Doping Test of Paris 2024 Olympics

Iraqi Judoka Fails First Doping Test of Paris 2024 Olympics

The International Testing Agency (ITA) has confirmed the first positive doping test of the 2024 Paris Olympics, involving Iraqi judoka Sajjad Sehen. The athlete tested positive for banned anabolic steroids methandienone and boldenone during an out-of-competition anti-doping control in Paris.

The ITA revealed that Sehen’s sample “returned an adverse analytical finding for the non-specified prohibited substances metandienone and boldenone.” Both drugs are prohibited by the World Anti-Doping Agency (WADA). The sample was collected on Tuesday and the result was reported by the WADA-accredited laboratory of Paris on Thursday.

The 28-year-old Sehen, a first-time Olympian, was scheduled to compete in the men’s 81-kilogram class next week. However, he has been provisionally suspended until the resolution of the matter.

“This means that the athlete is prevented from competing, training, coaching, or participating in any activity during the Olympic Games Paris 2024,” the ITA statement said.

Herda Raouf, the manager of Iraq’s delegation, stated that Sehen and his coach will be questioned by doping chiefs on Saturday. Raouf suggested that Sehen may have taken medication due to a recent surgical operation.

Sehen has the right to challenge his provisional suspension at the Court of Arbitration for Sport and can also request an analysis of the B sample. The ITA manages an independent anti-doping program for the Paris Olympics on behalf of the International Olympic Committee.

This incident highlights the importance of anti-doping measures in ensuring fair play and protecting the integrity of the Olympic Games. The ITA’s swift action in detecting and reporting the positive test sends a strong message that doping will not be tolerated.

Wimbledon Girls Finalist Nikola Bartunkova Suspended for Doping

Wimbledon Girls Finalist Nikola Bartunkova Suspended for Doping

Wimbledon Girls Finalist Nikola Bartunkova Provisionally Suspended for Doping

Nikola Bartunkova, the 18-year-old Czech tennis player who reached the Wimbledon girls’ singles final last year, has been provisionally suspended by the International Tennis Integrity Agency (ITIA) for doping.

The ITIA announced on Thursday that Bartunkova tested positive for trimetazidine, a banned heart medication, at tournaments in Trnava, Slovakia, and Maribor, Slovenia, in February and March, respectively. Trimetazidine, also known as TMZ, is a medication used to treat angina, a condition that causes chest pain. It is banned in sports because it can enhance endurance and performance.

Bartunkova’s positive tests are the latest in a series of high-profile cases involving TMZ. In 2021, Russian figure skater Kamila Valieva tested positive for the medication at the Beijing Winter Olympics, sparking a major controversy. Additionally, 23 Chinese swimmers were found to have used TMZ while preparing for the Tokyo Olympics.

Bartunkova, who is currently ranked 282nd in the world, has been banned from all sanctioned tennis events pending an ITIA hearing. She reached the singles semifinals and the doubles final at the 2022 Junior Roland Garros, and was considered one of the rising stars in women’s tennis.

The ITIA’s investigation into Bartunkova’s case is ongoing, and it is unclear at this time what penalties she may face if found guilty of doping. The agency has a zero-tolerance policy for doping and has been cracking down on the use of performance-enhancing substances in tennis.

The news of Bartunkova’s suspension is a blow to the sport of tennis and raises concerns about the prevalence of doping among young athletes. It is important for all athletes to compete fairly and ethically, and the ITIA’s efforts to combat doping are essential to maintaining the integrity of the sport.

Simona Halep Recounts Devastating Moment of Doping Revelation

Simona Halep Recounts Devastating Moment of Doping Revelation

Simona Halep, the former world No. 1 tennis player, has opened up about the devastating moment she discovered she had tested positive for a banned substance. In an exclusive interview with Tennis Channel, Halep described the news as a “truck hitting” her.

“It was like, ‘It’s a mistake. It cannot be true, this one,'” Halep recalled. “It was a really big pain when this happened, and I never thought that I can live something like this.”

Halep, a two-time Grand Slam champion, had never before been accused of doping. The revelation that she had tested positive for roxadustat, a performance-enhancing substance, sent shockwaves through the tennis world.

“It was really, really difficult,” Halep said. “Firstly because I didn’t know how it happened. And then when I discovered the contaminated supplement, it was a little bit better because you know what happened at least. But yeah, still, it was a disaster to live that emotion.”

Halep claimed that the roxadustat entered her system through a contaminated supplement she began taking before the 2022 US Open. She was provisionally suspended in October 2022 and initially faced a four-year ban. However, the Court of Arbitration for Sport (CAS) overturned her Athlete Biological Passport (ABP) conviction and declared she bore “no significant fault” for the presence of roxadustat in her system.

Halep’s suspension was reduced to 18 months, and she returned to action at the Miami Open in March. However, she has been sidelined again due to injuries.

In the interview, Halep spoke about her state of mind during her suspension and her plans to return to action. She expressed her gratitude for the support she received from her family, friends, and fans.

“I’m just trying to stay positive and focus on the things that I can control,” Halep said. “I’m working hard to get back to my best level and I’m excited to see what the future holds.”

Ryan Garcia Fails Drug Test After Victory Over Devin Haney

Ryan Garcia Fails Drug Test After Victory Over Devin Haney

American boxer Ryan Garcia’s stunning victory over Devin Haney last month has been marred by allegations of doping. ESPN reported that Garcia tested positive for the banned substance Ostarine on the day before and the morning of the April 20 bout. The report also suggests that Garcia may have tested positive for another banned substance, 19-norandrosterone, although this result is unconfirmed.

Ostarine is a performance-enhancing drug used to prevent muscle loss and improve lean body mass. It is commonly used in the treatment of women with breast cancer. Garcia’s positive test results have raised questions about the legitimacy of his victory over Haney, who retained his WBC super-lightweight title.

Garcia has vehemently denied any wrongdoing, claiming that the allegations are “fake news.” He has suggested that a tainted herbal supplement may be responsible for the positive test result. However, the Voluntary Anti-Doping Association (VADA), which oversees drug-testing in boxing and mixed martial arts, has confirmed the authenticity of the test results.

The allegations against Garcia have sent shockwaves through the boxing world. If proven true, they could result in Garcia facing a lengthy suspension and potentially losing his victory over Haney. The incident has also raised concerns about the prevalence of doping in boxing and the need for stricter drug-testing measures.

Garcia’s case is a reminder that even the most talented athletes are not immune to the temptation of using performance-enhancing drugs. It is essential for boxing authorities to continue to crack down on doping and ensure that the sport remains fair and competitive.

Halep's Miami Wild Card Sparks Debate on Doping and Fair Play

Halep’s Miami Wild Card Sparks Debate on Doping and Fair Play

Simona Halep’s Miami Wild Card Sparks Debate on Doping and Fair Play

Simona Halep’s successful appeal for a wild card entry into the Miami Open has reignited the debate on the role of doping in professional tennis. Former world No. 1 Kim Clijsters and Andy Roddick discussed the issue on their podcast, “Served with Andy Roddick.”

Clijsters expressed support for Halep, who tested positive for a banned substance in 2022 but claimed it was an unintentional ingestion. “Halep’s situation is completely different,” Clijsters said. “She tested positive unknowingly.”

However, former world No. 1 Caroline Wozniacki voiced her disapproval of the tournament’s decision to grant Halep a wild card. “She was very cautious when she said it, but basically she doesn’t believe people who have doped should be back and be given wild cards,” Roddick said.

Roddick disagreed with Wozniacki, arguing that Halep’s presence in the tournament was good for business. “It’s a business, and you want [Halep] as a storyline,” he said.

Clijsters acknowledged the complexity of the issue. “When someone tests positive for taking something to become a better athlete, then I one hundred percent agree with Caroline,” she said. “But Halep’s situation is different.”

The debate also touched on Halep’s previous comments about Maria Sharapova, who received a wild card after serving a doping suspension in 2017. Halep had said at the time that she believed dopers should not be allowed wild cards.

“Her saying something about Maria in the past shows her vision of how she looks at doping and that she’s not a cheater,” Clijsters said. “In [Halep’s] mind, she didn’t cheat, and I do believe that.”

The podcast also discussed the broader issue of doping in tennis and the sport’s meticulous drug testing protocols. They also touched on the recent $2 billion Saudi Arabia deal on the table for the ATP Tour and the potential implications for the sport.

Syringes Found at Athletics Championship, Raising Doping Concerns

Syringes Found at Athletics Championship, Raising Doping Concerns

The Athletics Federation of India’s (AFI) “no needle policy” has come under scrutiny after numerous used syringes were discovered at the main athletics stadium of the Sports Authority of India’s center in Lucknow during the 22nd Junior National Federation Athletics Championship.

The syringes were found scattered in the men’s toilets, which are adjacent to the dope collection rooms at the venue. The identity of the athletes who used the syringes remains unknown, but their presence raises concerns about potential doping violations.

“We can’t keep an eye on every athlete, especially when they lock the toilet doors,” said a security guard outside the bathrooms on condition of anonymity. “It’s not our responsibility to check every time an athlete comes out of the toilet.”

The discovery of the syringes on the first day of the prestigious event, which serves as a qualifying championship for the 21st Asian U20 Athletics Championships in Dubai, has shocked organizers.

“We have no idea how these syringes got into the men’s toilet,” said PK Srivastava, chief executive officer of the Uttar Pradesh Athletics Association. “We have a strict no-needle policy in athletics, but I will investigate this matter personally.”

Srivastava confirmed that the AFI has set up a dope control center at the venue, where a team of doctors is deputed for sample collection. A six-member NADA team led by BN Mishra is also stationed there.

“AFI has set up its dope controlling center at the venue, and so far, nine samples have been received on day one of the three-day championship,” said Srivastava. “It’s disheartening that some of our athletes still resort to such unethical practices.”

The presence of the syringes has cast a shadow over the championship and raised questions about the effectiveness of the AFI’s anti-doping measures. The incident highlights the need for stricter enforcement of doping regulations and increased education for athletes on the dangers of performance-enhancing substances.

Simona Halep Returns to Tennis After Doping Suspension Reduced

Simona Halep Returns to Tennis After Doping Suspension Reduced

Simona Halep, the former world No. 1 and two-time Grand Slam champion, is set to make her long-awaited return to tennis at the Miami Open later this month. The Romanian star’s comeback comes after a successful appeal of her doping suspension, which was reduced from four years to nine months.

Halep tested positive for a banned substance at the 2022 U.S. Open, leading to her provisional suspension from the sport. She has consistently maintained her innocence, arguing that the positive test resulted from a contaminated supplement.

The Court of Arbitration for Sport (CAS) ruled in Halep’s favor on Tuesday, acknowledging that while she bore some responsibility for not exercising sufficient care in using the supplement, her actions did not constitute significant fault or negligence. The court also emphasized that Halep’s anti-doping rule violations were not intentional.

Halep’s return to tennis has been met with excitement from fans and fellow players alike. The 32-year-old has been a dominant force in the sport, winning Wimbledon in 2019 and the French Open in 2018. Her return to the court is expected to add a new level of intrigue to the upcoming Miami Open.

Halep’s case has highlighted the complexities of anti-doping regulations and the importance of due process. The CAS ruling has provided a measure of vindication for Halep, who has always maintained her innocence. It also serves as a reminder that athletes must exercise the utmost caution when using supplements or other substances that could potentially contain banned substances.

As Halep prepares for her return to competition, she will undoubtedly be eager to prove that she is still a force to be reckoned with. Her presence at the Miami Open will undoubtedly add to the excitement and anticipation surrounding the tournament.

Simona Halep Cleared to Return to Tennis After Doping Ban Reduced

Simona Halep Cleared to Return to Tennis After Doping Ban Reduced

Simona Halep Cleared to Return to Tennis After Doping Ban Reduced

Two-time Grand Slam champion Simona Halep has been cleared to return to tennis immediately after the Court of Arbitration for Sport (CAS) reduced her four-year doping ban to nine months on appeal. The ban was applied retroactively and expired last July.

Halep tested positive for the banned blood-boosting substance Roxadustat at the 2022 U.S. Open. She has maintained her innocence, claiming that the substance entered her body through a contaminated supplement.

The CAS judges agreed with Halep’s argument, stating that she had “established, on the balance of probabilities” that the positive test was not due to intentional doping. They noted that Halep had a clean doping record and had never tested positive for any other banned substances.

Halep’s ban was originally set to expire in October 2026, but the CAS ruling means she can now resume her tennis career immediately. The 31-year-old Romanian has not played since the 2022 U.S. Open and will be eager to make her return to the court.

Halep’s return is a major boost for women’s tennis. She is one of the most successful players of her generation, having won the French Open in 2018 and 2019 and the Wimbledon title in 2019. She has also been ranked world number one on multiple occasions.

The CAS ruling is a significant victory for Halep and her team. It is a testament to her determination and resilience that she has been able to clear her name and return to the sport she loves.

Home
Shop
Wishlist0
Back to Top

Search For Products

Product has been added to your cart